Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not suppress blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with prior TIA or stroke: A randomized substudy of the Vitatops (vitamin

---

Autoria(s): Hankey, GJ; Eikelbloom, P; Dusitanond, P; Thom, J; Loh, K; van Bockxmeer, F; Jamrozik, K

Data(s)	01/01/2005
Identificador	http://espace.library.uq.edu.au/view/UQ:44589
Idioma(s)	eng
Palavras-Chave	#Clinical Neurology #Peripheral Vascular Disease
Tipo	Journal Article